| Literature DB >> 28836413 |
Amir Almasi-Hashiani1, Azadeh Ghaheri1, Reza Omani Samani2.
Abstract
OBJECTIVES: In assisted reproductive technology, it is important to choose high quality embryos for embryo transfer. The aim of the present study was to determine the grade A embryo count and factors related to it in infertile women.Entities:
Keywords: Assisted Reproductive Technology; Cleavage Stage; Embryo Research; Poisson Distribution; Zygote
Year: 2017 PMID: 28836413 PMCID: PMC5570415 DOI: 10.22074/cellj.2017.4214
Source DB: PubMed Journal: Cell J ISSN: 2228-5806 Impact factor: 2.479
Fig.1The frequency of grade A embryo in infertile women.
The baseline characteristics of participants in the study
| Variable | Mean | SD | 95% CI for mean |
|---|---|---|---|
| Age of mother (Y) | 35.49 | 5.33 | 35.16-35.82 |
| BMI (kg/m2) | 25.56 | 3.88 | 25.32-25.81 |
| hCG injection day | 12.36 | 2.55 | 12.20-12.52 |
| Cleavage day | 1.51 | 0.70 | 1.46-1.55 |
| Stimulation day | 9.70 | 1.68 | 9.57-9.84 |
| 1PN number | 0.22 | 0.57 | 0.19-0.26 |
| 2PN number | 4.33 | 3.17 | 4.13-4.53 |
| Number of injected oocyte | 7.42 | 4.15 | 7.15-7.68 |
| Metaphase I number | 0.47 | 1.12 | 0.40-0.54 |
| Metaphase II number | 7.11 | 4.22 | 6.85-7.38 |
| GV number | 0.48 | 1.20 | 0.40-0.55 |
| Ampoule number | 29.20 | 13.04 | 28.38-30.02 |
| Previous ART number | 1.36 | 0.48 | 1.33-1.39 |
| Duration of fertility prevention in year | 6.96 | 5.20 | 6.63-7.29 |
| Duration of infertility in year | 0.89 | 1.83 | 0.78-1.01 |
CI; Confidence interval, BMI; Body mass index, hCG; Human chorionic gonadotropin, PN; Pronucleus zygotes, GV; Germinal vesicles, and ART; Assisted reproductive technology.
The crude and adjusted incidence rate ratio (IRR) for the number of grade A embryos
| Crude analysis | Adjusted analysis with ZIP model* | Adjusted analysis with ZINB model* | |||||||
|---|---|---|---|---|---|---|---|---|---|
| IRR | 95% CI | P | IRR | 95% CI | P | IRR | 95% CI | P | |
| Age of mother (Y) | 0.97 | 0.94-1.01 | 0.068 | 0.99 | 0.95-1.03 | 0.818 | 0.97 | 0.91-1.04 | 0.545 |
| BMI (kg/m2) | 0.99 | 0.95-1.03 | 0.819 | 1.01 | 0.94-1.06 | 0.878 | 1.06 | 0.98-1.15 | 0.140 |
| hCG injection day | 1.03 | 0.98-1.08 | 0.181 | 1.08 | 0.94-1.23 | 0.251 | 1.10 | 0.92-1.31 | 0.271 |
| Cleavage day | 0.45 | 0.31-0.65 | <0.001 | 0.60 | 0.39-0.94 | 0.027 | 0.35 | 0.20-0.61 | 0.001 |
| Stimulation day | 0.99 | 0.89-1.11 | 0.962 | 0.88 | 0.78-1.01 | 0.073 | 0.91 | 0.75-1.09 | 0.329 |
| 1PN number | 1.09 | 0.90-1.32 | 0.347 | 1.52 | 0.99-2.34 | 0.054 | 1.56 | 0.88-2.75 | 0.120 |
| 2PN number | 1.13 | 1.09-1.17 | <0.001 | 1.32 | 1.17-1.48 | 0.001 | 1.45 | 1.23-1.69 | 0.001 |
| Number of injected oocyte | 1.08 | 1.05-1.12 | <0.001 | 0.82 | 0.63-1.07 | 0.157 | 0.78 | 0.57-1.06 | 0.123 |
| Metaphase I number | 0.98 | 0.86-1.10 | 0.750 | 1.02 | 0.81-1.28 | 0.841 | 1.08 | 0.82-1.43 | 0.566 |
| Metaphase II number | 1.06 | 1.03-1.10 | <0.001 | 1.02 | 0.80-1.30 | 0.836 | 1.06 | 0.79-1.42 | 0.665 |
| GV number | 0.94 | 0.77-1.15 | 0.572 | 1.08 | 0.86-1.35 | 0.501 | 1.09 | 0.78-1.51 | 0.607 |
| Ampoule number | 0.99 | 0.97-1.004 | 0.196 | 0.98 | 0.96-1.01 | 0.363 | 0.99 | 0.96-1.02 | 0.710 |
| Previous ART number | 0.90 | 0.82-1.007 | 0.068 | 0.92 | 0.79-1.06 | 0.280 | 0.65 | 0.35-1.18 | 0.162 |
| Duration of fertility prevention (Y) | 0.99 | 0.91-1.08 | 0.964 | 1.03 | 0.92-1.15 | 0.554 | .098 | 0.92-1.05 | 0.639 |
| Duration of infertility (Y) | 0.97 | 0.94-1.007 | 0.134 | 1.01 | 0.95-1.04 | 0.999 | 1.05 | 0.88-1.25 | 0.546 |
CI; Confidence interval, BMI; Body mass index, hCG; Human chorionic gonadotropin, PN; Pronucleus zygotes, GV; Germinal vesicles, ART; Assisted reproductive technology, ZIP; Zero Inflated Poisson, ZINB; Zero Inflated Negative Binomial, and *; Adjusted for other variables in the Table.